Focai Bio

Focai Bio is a biotechnology firm that integrates experimental spatial measurement techniques with AI-driven analytics to assess drug distribution and targeting at the single-cell level within intact complex tissues. Focusing on radiopharmaceuticals which deliver radiation in physical proximity to their target, they predict and quantify therapeutic delivery and distribution more precisely and earlier in the drug development pipeline. This addresses the critical issue of incomplete therapeutic targeting and poor therapeutic index, a major contributor to clinical trial failure where existing imaging and pathology methods fall short, by quantifying the delivery, spatial distribution, and target saturation of the therapeutic. Relevance to Patients: Many cancer therapies fail because drugs don’t reach tumors effectively, leading to relapse and treatment failure for patients. Focai Bio is able to accurately predict and improve drug delivery so treatments can be designed and dosed for the patients most likely to benefit.